NLS Pharmaceutics AG
General ticker "NLSP" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $105.0M
NLS Pharmaceutics AG does not follow the US Stock Market performance with the rate: -40.0%.
Estimated limits based on current volatility of 10.7%: low 1.92$, high 2.38$
Short-term NLSP quotes
Long-term NLSP plot
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $11.81MM |
| Operating Income | $-11.81MM |
| Non-Operating Income | $-0.36MM |
| Interest Expense | $0.15MM |
| R&D Expense | $5.91MM |
| Income(Loss) | $-12.17MM |
| Profit(Loss) | $-12.17MM |
| Stockholders Equity | $-8.83MM |
| Assets | $1.85MM |
| Operating Cash Flow | $-9.68MM |
| Capital expenditure | $0.00MM |
| Financing Cash Flow | $1.63MM |
| Earnings Per Share* | $-0.32 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.